Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 9, Pages 3900-3908
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2017-01-12
DOI
10.1074/jbc.m116.767749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
- (2016) Tilman Schlothauer et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a
- (2015) E. Arduin et al. MOLECULAR IMMUNOLOGY
- Alternative molecular formats and therapeutic applications for bispecific antibodies
- (2015) Christoph Spiess et al. MOLECULAR IMMUNOLOGY
- Amgen's bispecific antibody puffs across finish line
- (2015) Cormac Sheridan NATURE BIOTECHNOLOGY
- Biopharmaceutical benchmarks 2014
- (2014) Gary Walsh NATURE BIOTECHNOLOGY
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
- (2013) Maya K Leabman et al. mAbs
- Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
- (2013) Whitney Shatz et al. mAbs
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- (2013) Christoph Spiess et al. NATURE BIOTECHNOLOGY
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1
- (2012) Thomas C. Nesspor et al. JOURNAL OF MOLECULAR RECOGNITION
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- With or Without Sugar? (A)glycosylation of Therapeutic Antibodies
- (2012) Dmitrij Hristodorov et al. MOLECULAR BIOTECHNOLOGY
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Enhancement of DNA uptake in FUT8-deleted CHO cells for transient production of afucosylated antibodies
- (2010) Athena W. Wong et al. BIOTECHNOLOGY AND BIOENGINEERING
- Identification of IgG1 variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: Comparison of soluble receptor-based and cell-based binding assays
- (2010) Yanmei Lu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors
- (2008) S. L. Sazinsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now